Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
valneva.com/press-release/…
Valneva
@valnevaSE
We are a specialty vaccine company that develops, manufactures and commercializes prophylactic vaccines for infectious diseases, addressing unmet medical needs.
